Gilead Sciences, Inc. (GILD) Earnings Yield: 5.85%
Is Gilead Sciences, Inc.’s earnings yield high or low?
Gilead Sciences, Inc.'s earnings yield of 5.85% is 34% above its 5-year average of 4.37%, around the middle of its 5-year range (0.08%–9.61%).
The earnings yield for Gilead Sciences, Inc. (GILD) is 5.85% as of Tuesday, June 9, 2026. It is above its 12-month average by 23.77% (4.73%).
GILD Earnings Yield Chart
GILD Average Earnings Yield Chart
GILD Current vs Average Earnings Yield Chart
GILD Earnings Yield Metrics
EARNINGS YIELD
5.85%
EARNINGS YIELD AVG TTM
4.73%
EARNINGS YIELD AVG 3Y
3.68%
EARNINGS YIELD AVG 5Y
4.37%
EARNINGS YIELD AVG 10Y
5.81%
EARNINGS YIELD AVG 15Y
5.96%
EARNINGS YIELD AVG 20Y
5.66%
CURRENT VS TTM AVG
+23.77%
CURRENT VS 3Y AVG
+58.81%
CURRENT VS 5Y AVG
+33.98%
CURRENT VS 10Y AVG
+0.69%
CURRENT VS 15Y AVG
-1.85%
CURRENT VS 20Y AVG
+3.36%
GILD Competitors' Earnings Yield
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. (GILD) | — | 5.85% | 4.73% | 3.68% | 4.37% |
| Abbott Laboratories (ABT) | $158.94B | 3.93% | 5.51% | 4.05% | 3.87% |
| Intuitive Surgical, Inc. (ISRG) | $151.09B | 1.93% | 1.54% | 1.36% | 1.43% |
| Pfizer Inc. (PFE) | $146.48B | 5.10% | 6.28% | 5.54% | 6.84% |
| Danaher Corporation (DHR) | $133.37B | 2.74% | 2.43% | 2.72% | 3.03% |
| Thermo Fisher Scientific Inc. (TMO) | $183.61B | 3.68% | 3.48% | 3.13% | 3.26% |
| Amgen Inc. (AMGN) | $185.96B | 4.17% | 4.00% | 3.83% | 4.18% |
| CVS Health Corporation (CVS) | $123.84B | 2.34% | 2.93% | 5.90% | 5.70% |
| Bristol-Myers Squibb Company (BMY) | $115.34B | 6.30% | 5.69% | 6.70% | 5.30% |
| Vertex Pharmaceuticals Incorporated (VRTX) | $113.14B | 3.78% | 3.39% | 3.39% | 3.65% |
Earnings Yield vs P/E Ratio
Earnings Yield
5.85%
EPS ÷ Price
P/E Ratio
17.1
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
- It expresses earnings relative to share price as a percentage
- It can be compared with FCF yield and dividend yield
- It can be compared with bond yields because both are percentages
- It is mathematically the inverse of the P/E ratio
Gilead Sciences, Inc. Earnings Yield Formula & Definition
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Gilead Sciences, Inc. Earnings Yield FAQ
- What is the earnings yield for Gilead Sciences, Inc. (GILD)?
- The earnings yield for GILD stock is 5.85%.
- Is Gilead Sciences, Inc.'s earnings yield high or low?
- Gilead Sciences, Inc.'s earnings yield of 5.85% is 34% above its 5-year average of 4.37%, around the middle of its 5-year range (0.08%–9.61%).
- What is the TTM average earnings yield for Gilead Sciences, Inc. (GILD)?
- The TTM average earnings yield for GILD stock is 4.73%.
- What is the 3Y average earnings yield for Gilead Sciences, Inc. (GILD)?
- The 3Y average earnings yield for GILD stock is 3.68%.
- What is the 5Y average earnings yield for Gilead Sciences, Inc. (GILD)?
- The 5Y average earnings yield for GILD stock is 4.37%.
- What is the 10Y average earnings yield for Gilead Sciences, Inc. (GILD)?
- The 10Y average earnings yield for GILD stock is 5.81%.
- What is the 15Y average earnings yield for Gilead Sciences, Inc. (GILD)?
- The 15Y average earnings yield for GILD stock is 5.96%.
- What is the 20Y average earnings yield for Gilead Sciences, Inc. (GILD)?
- The 20Y average earnings yield for GILD stock is 5.66%.
Gilead Sciences, Inc. Earnings Yield History
| DATE | EARNINGS YIELD |
|---|---|
| 2026-06-09 | 5.85% |
| 2026-06-08 | 5.73% |
| 2026-06-05 | 5.68% |
| 2026-06-04 | 5.68% |
| 2026-06-03 | 5.69% |
| 2026-06-02 | 5.75% |
| 2026-06-01 | 5.60% |
| 2026-05-29 | 5.46% |
| 2026-05-28 | 5.39% |
| 2026-05-27 | 5.49% |
| 2026-05-26 | 5.49% |
| 2026-05-22 | 5.46% |
| 2026-05-21 | 5.62% |
| 2026-05-20 | 5.61% |
| 2026-05-19 | 5.62% |
| 2026-05-18 | 5.66% |
| 2026-05-15 | 5.67% |
| 2026-05-14 | 5.56% |
| 2026-05-13 | 5.52% |
| 2026-05-12 | 5.44% |
| 2026-05-11 | 5.50% |
| 2026-05-08 | 5.59% |
| 2026-05-07 | 5.48% |
| 2026-05-06 | 4.97% |
| 2026-05-05 | 5.07% |
| 2026-05-04 | 5.10% |
| 2026-05-01 | 5.14% |
| 2026-04-30 | 5.17% |
| 2026-04-29 | 5.25% |
| 2026-04-28 | 5.24% |
| 2026-04-27 | 5.30% |
| 2026-04-24 | 5.19% |
| 2026-04-23 | 5.07% |
| 2026-04-22 | 5.09% |
| 2026-04-21 | 5.08% |
| 2026-04-20 | 4.98% |
| 2026-04-17 | 4.92% |
| 2026-04-16 | 4.89% |
| 2026-04-15 | 4.84% |
| 2026-04-14 | 4.82% |
| 2026-04-13 | 4.87% |
| 2026-04-10 | 4.87% |
| 2026-04-09 | 4.76% |
| 2026-04-08 | 4.78% |
| 2026-04-07 | 4.88% |
| 2026-04-06 | 4.83% |
| 2026-04-02 | 4.84% |
| 2026-04-01 | 4.83% |
| 2026-03-31 | 4.86% |
| 2026-03-30 | 4.97% |
| 2026-03-27 | 5.04% |
| 2026-03-26 | 4.95% |
| 2026-03-25 | 4.90% |
| 2026-03-24 | 4.90% |
| 2026-03-23 | 4.93% |
| 2026-03-20 | 4.93% |
| 2026-03-19 | 4.80% |
| 2026-03-18 | 4.79% |
| 2026-03-17 | 4.69% |
| 2026-03-16 | 4.66% |
| 2026-03-13 | 4.67% |
| 2026-03-12 | 4.66% |
| 2026-03-11 | 4.64% |
| 2026-03-10 | 4.56% |
| 2026-03-09 | 4.62% |
| 2026-03-06 | 4.70% |
| 2026-03-05 | 4.66% |
| 2026-03-04 | 4.57% |
| 2026-03-03 | 4.58% |
| 2026-03-02 | 4.51% |
| 2026-02-27 | 4.55% |
| 2026-02-26 | 4.71% |
| 2026-02-25 | 4.60% |
| 2026-02-24 | 4.59% |
| 2026-02-23 | 4.30% |
| 2026-02-20 | 4.26% |
| 2026-02-19 | 4.27% |
| 2026-02-18 | 4.22% |
| 2026-02-17 | 4.15% |
| 2026-02-13 | 4.16% |
| 2026-02-12 | 4.25% |
| 2026-02-11 | 4.14% |
| 2026-02-10 | 4.38% |
| 2026-02-09 | 4.25% |
| 2026-02-06 | 4.23% |
| 2026-02-05 | 4.32% |
| 2026-02-04 | 4.41% |
| 2026-02-03 | 4.50% |
| 2026-02-02 | 4.51% |
| 2026-01-30 | 4.54% |
| 2026-01-29 | 4.62% |
| 2026-01-28 | 4.62% |
| 2026-01-27 | 4.57% |
| 2026-01-26 | 4.68% |
| 2026-01-23 | 4.75% |
| 2026-01-22 | 4.92% |
| 2026-01-21 | 5.00% |
| 2026-01-20 | 5.19% |
| 2026-01-16 | 5.16% |
| 2026-01-15 | 5.32% |
| 2026-01-14 | 5.20% |
| 2026-01-13 | 5.30% |
| 2026-01-12 | 5.26% |
| 2026-01-09 | 5.32% |
| 2026-01-08 | 5.34% |
| 2026-01-07 | 5.19% |
| 2026-01-06 | 5.31% |
| 2026-01-05 | 5.45% |
| 2026-01-02 | 5.31% |
| 2025-12-31 | 5.25% |
| 2025-12-30 | 5.24% |
| 2025-12-29 | 5.16% |
| 2025-12-26 | 5.17% |
| 2025-12-24 | 5.13% |
| 2025-12-23 | 5.15% |
| 2025-12-22 | 5.19% |
| 2025-12-19 | 5.19% |
| 2025-12-18 | 5.31% |
| 2025-12-17 | 5.31% |
| 2025-12-16 | 5.43% |
| 2025-12-15 | 5.39% |
| 2025-12-12 | 5.36% |
| 2025-12-11 | 5.24% |
| 2025-12-10 | 5.32% |
| 2025-12-09 | 5.40% |
| 2025-12-08 | 5.32% |
| 2025-12-05 | 5.32% |
| 2025-12-04 | 5.26% |
| 2025-12-03 | 5.16% |
| 2025-12-02 | 5.21% |
| 2025-12-01 | 5.19% |
| 2025-11-28 | 5.13% |
| 2025-11-26 | 5.06% |
| 2025-11-25 | 5.07% |
| 2025-11-24 | 5.15% |
| 2025-11-21 | 5.09% |
| 2025-11-20 | 5.16% |
| 2025-11-19 | 5.04% |
| 2025-11-18 | 5.07% |
| 2025-11-17 | 5.20% |
| 2025-11-14 | 5.16% |
| 2025-11-13 | 5.15% |
| 2025-11-12 | 5.23% |
| 2025-11-11 | 5.26% |
| 2025-11-10 | 5.46% |
| 2025-11-07 | 5.43% |
| 2025-11-06 | 4.07% |
| 2025-11-05 | 4.10% |
| 2025-11-04 | 4.08% |
| 2025-11-03 | 4.11% |
| 2025-10-31 | 4.19% |
| 2025-10-30 | 4.24% |
| 2025-10-29 | 4.24% |
| 2025-10-28 | 4.26% |
| 2025-10-27 | 4.17% |
| 2025-10-24 | 4.15% |
| 2025-10-23 | 4.16% |
| 2025-10-22 | 4.13% |
| 2025-10-21 | 4.05% |
| 2025-10-20 | 4.08% |
| 2025-10-17 | 4.09% |
| 2025-10-16 | 4.26% |
| 2025-10-15 | 4.24% |
| 2025-10-14 | 4.24% |
| 2025-10-13 | 4.25% |
| 2025-10-10 | 4.28% |
| 2025-10-09 | 4.30% |
| 2025-10-08 | 4.24% |
| 2025-10-07 | 4.30% |
| 2025-10-06 | 4.42% |
| 2025-10-03 | 4.45% |
| 2025-10-02 | 4.54% |
| 2025-10-01 | 4.52% |
| 2025-09-30 | 4.52% |
| 2025-09-29 | 4.46% |
| 2025-09-26 | 4.48% |
| 2025-09-25 | 4.52% |
| 2025-09-24 | 4.42% |
| 2025-09-23 | 4.39% |
| 2025-09-22 | 4.46% |
| 2025-09-19 | 4.40% |
| 2025-09-18 | 4.42% |
| 2025-09-17 | 4.47% |
| 2025-09-16 | 4.53% |
| 2025-09-15 | 4.46% |
| 2025-09-12 | 4.38% |
| 2025-09-11 | 4.26% |
| 2025-09-10 | 4.36% |
| 2025-09-09 | 4.34% |
| 2025-09-08 | 4.33% |
| 2025-09-05 | 4.36% |
| 2025-09-04 | 4.45% |
| 2025-09-03 | 4.44% |
| 2025-09-02 | 4.45% |
| 2025-08-29 | 4.44% |
| 2025-08-28 | 4.46% |
| 2025-08-27 | 4.41% |
| 2025-08-26 | 4.37% |
| 2025-08-25 | 4.40% |
| 2025-08-22 | 4.37% |
| 2025-08-21 | 4.32% |
| 2025-08-20 | 4.23% |
| 2025-08-19 | 4.26% |
| 2025-08-18 | 4.26% |
| 2025-08-15 | 4.24% |
| 2025-08-14 | 4.22% |
| 2025-08-13 | 4.18% |
| 2025-08-12 | 4.18% |
| 2025-08-11 | 4.17% |
| 2025-08-08 | 4.20% |
| 2025-08-07 | 4.55% |
| 2025-08-06 | 4.31% |
| 2025-08-05 | 4.22% |
| 2025-08-04 | 4.15% |
| 2025-08-01 | 4.20% |
| 2025-07-31 | 4.23% |
| 2025-07-30 | 4.14% |
| 2025-07-29 | 4.16% |
| 2025-07-28 | 4.20% |
| 2025-07-25 | 4.09% |
| 2025-07-24 | 4.20% |
| 2025-07-23 | 4.18% |
| 2025-07-22 | 4.31% |
| 2025-07-21 | 4.39% |
| 2025-07-18 | 4.39% |
| 2025-07-17 | 4.36% |
| 2025-07-16 | 4.32% |
| 2025-07-15 | 4.36% |
| 2025-07-14 | 4.24% |
| 2025-07-11 | 4.33% |
| 2025-07-10 | 4.15% |
| 2025-07-09 | 4.19% |
| 2025-07-08 | 4.28% |
| 2025-07-07 | 4.25% |
| 2025-07-03 | 4.25% |
| 2025-07-02 | 4.26% |
| 2025-07-01 | 4.25% |
| 2025-06-30 | 4.28% |
| 2025-06-27 | 4.29% |
| 2025-06-26 | 4.41% |
| 2025-06-25 | 4.48% |
| 2025-06-24 | 4.43% |
| 2025-06-23 | 4.47% |
| 2025-06-20 | 4.38% |
| 2025-06-18 | 4.40% |
| 2025-06-17 | 4.40% |
| 2025-06-16 | 4.29% |
| 2025-06-13 | 4.32% |
| 2025-06-12 | 4.24% |
| 2025-06-11 | 4.35% |
| 2025-06-10 | 4.31% |
| 2025-06-09 | 4.20% |
| 2025-06-06 | 4.22% |
| 2025-06-05 | 4.30% |
| 2025-06-04 | 4.36% |
| 2025-06-03 | 4.34% |
| 2025-06-02 | 4.36% |
| 2025-05-30 | 4.32% |
| 2025-05-29 | 4.28% |
| 2025-05-28 | 4.38% |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Gilead Sciences, Inc.
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Daniel O'Day